Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
22,374
-
Shares change
-
-17,451,498
-
Total reported value, excl. options
-
$105,000
-
Value change
-
-$23,115,620
-
Number of sells
-
-42
-
Price
-
$4.69
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q1 2020
45 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q1 2020.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,374 shares
.
Largest 10 shareholders include X-Square Capital, LLC (22,374 shares), Sumitomo Mitsui Trust Holdings, Inc. (0 shares), PERSONAL CFO SOLUTIONS, LLC (0 shares), MCDANIEL TERRY & CO (0 shares), CITIGROUP INC (0 shares), ALGERT GLOBAL LLC (0 shares), DEUTSCHE BANK AG\ (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), WELLS FARGO & COMPANY/MN (0 shares), and OXFORD ASSET MANAGEMENT LLP (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.